Apogee Therapeutics, Inc.
Clinical trials sponsored by Apogee Therapeutics, Inc., explained in plain language.
A biotech company developing antibody therapies for inflammatory and immunologic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New asthma drug enters early human testing Results expected Sep 2026 (estimated)
- New eczema drug shows promise in Mid-Stage trial Results expected Nov 2026 (estimated)